Tackling high-grade neuroendocrine tumors, unlocking the mysteries of kidney cancer metabolism, making comprehensive cancer services more accessible, emerging trends after an FDA committee ruling favors using a new endpoint in multiple myeloma trials, and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center. The new trial will test the novel combination of immunotherapy paired with a tumor-busting virus.
As a cancer patient, it can be challenging to ask questions of your health care providers. Even though I am a trained journalist who practically asks questions for a living, I struggled with all the questions I had during the early parts of my cancer journey.
Rising leukemia rates in Florida linked to aging population, new treatment guidelines for follicular lymphoma, a new study that may help unlock immunotherapy for glioblastoma, and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Since 2021, when lung cancer screening guidelines began to include younger people and those with a lower smoking history, the number of screenings climbed, but significant gaps remain, especially among people with limited access to healthcare.
Glioblastoma is one of the toughest cancers to treat, but a new study suggests that suppressing a protein (ZNF638) triggers an antiviral immune response, making immune checkpoint inhibitors more effective. The discovery also identifies ZNF638 as a biomarker that could help personalize immunotherapy.
A new Sylvester Cancer study reveals Florida has the nation’s highest and fastest-growing leukemia rates, driven primarily by an influx of retirees, but it also uncovers a critical mismatch: many of the state’s leukemia “hotspots,” lack nearby specialized treatment, putting these residents at higher risk.
Electric vehicles are becoming more popular and are a growing segment of the nation’s automobile fleet. But public health researchers with Sylvester Comprehensive Cancer Center are discovering elevated cancer risks for firefighters and community members alike from electric vehicle fires.
Migraine is much more than just a headache. It is a debilitating disease that can drastically impact the lives of those affected, limiting their ability to work, study, travel, spend time with family, and enjoy everyday moments.
Protecting firefighters from occupational cancer risks, electric vehicle fires associated with higher cancer risks, connecting patients directly with pathologists to explain complex test results, using gene editing to battle mitochondrial diseases, and a profile of a brain cancer researcher are all in this month’s tip sheet.
Anyone on a cancer journey needs support from other people. On my journey, I was incredibly fortunate, says Rochelle Broder-Singer, a journalist and cancer survivor. Family, friends, fellow breast cancer survivors and others were there for her. Most important was her husband, Scott, who shares his experience in this article.
Sexual intimacy can be challenging for women treated for cancer, but the nationally recognized Menopause Urogenital Sexual Health and Intimacy Clinic (MUSIC) at Sylvester Comprehensive Cancer Center can help.
Firefighters are more likely to die of cancer than accidents or flames, but for 10 years, the nationally recognized Firefighter Cancer Initiative (FCI) at Sylvester Comprehensive Cancer Center, part of UHealth, the University of Miami Health System, has been working to cut that risk.
Breast cancer survivor Rochelle Broder-Singer is a journalist with over two decades of experience in journalism and communications. In addition to her professional achievements, Rochelle is currently writing a series of articles for Sylvester Comprehensive Cancer Center chronicling her cancer journey.
The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (UM) Miller School of Medicine have been selected to become the second U.S.-based site for Neuralink’s PRIME Study, an investigational medical device clinical trial for Neuralink’s ground-breaking brain-computer interface.
The FDA ban on Red Dye 3, cancer survivorship and what it means to live with cancer, global trends in lung cancer deaths, gynecologic disparities in women of African ancestry and more are included in this month's tip sheet from Sylvester Comprehensive Cancer Center.
Have a "mocktail" instead of a cocktail. It could reduce your risk for developing seven known types of cancer. In this article, Sylvester Comprehensive Cancer Center experts offer mocktail recipes and other tips on avoiding alcohol without feeling deprived.
Lung and related cancer deaths decreased in the world’s 10 most populous countries over the past 40 years, but there is still a pressing need for public health measures to further reduce tobacco use and related mortality and the cancer risk from air pollution and asbestos exposure.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
